AJJ Medtech Holdings Limited (584)
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
200-500%
💰 Dividend History
No dividend history available.
📅 SGX Earnings Announcements for 584
AJJ Medtech Holdings Limited (584)
Market: SGX |
Currency: SGD
Address: 8 Commonwealth Lane #02-04
AJJ Medtech Holdings Limited provides providing MedTech integrated solutions to healthcare sector in Singapore. It supplies medical devices with complementary digital, artificial intelligence (AI), and robotics solutions to customers and supplying partners. The company offers in-vitro diagnostics, including point of call diagnostics with focus on at-home monitoring and diagnostics, including blood glucose monitoring system and single-use test kits, as well as laboratory diagnostics and biobanking solutions with focus on solutions on diagnostics and academic research. The company also provides clinical stage cancer treatment device, including high-intensity focused ultrasound (HIFU), general and plastic surgery devices, and ward-side consumables. In addition, it distributes Samsung Medison ultrasound products; and dental supplies and intra-oralscanners, as well as provides management consultancy services for healthcare organizations. The company was formerly known as OEL (Holdings) Limited and changed its name to AJJ Medtech Holdings Limited in February 2024. AJJ Medtech Holdings Limited was incorporated in 1984 and is based in Singapore.
Show more
📈 AJJ Medtech Holdings Limited Historical Chart
📰 Related News & Research
🔍 View more Reports
